Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Indacaterol

Indacaterol was supplied in powder filled capsules together with a single-dose dry-powder inhaler (SDDPI) device.

DRUG

Salmeterol 50 μg

Salmeterol was supplied in the manufacturer's proprietary Diskus inhaler device.

DRUG

Placebo to indacaterol

Placebo to indacaterol was supplied in powder filled capsules together with a single-dose dry-powder inhaler (SDDPI) device.

DRUG

Placebo to salmeterol

Placebo to salmeterol was supplied in the manufacturer's proprietary Diskus inhaler device.

Trial Locations (69)

10538

Novartis Investigative Site, Larchmont

11023

Novartis Investigative Site, Great Neck

11042

Novartis Investigative Site, Lake Success

11361

Novartis Investigative Site, Bayside

15243

Novartis Investigative Site, Pittsburgh

19460

Novartis Investigative Site, Phoenixville

21044

Novartis Investigative Site, Columbia

22401

Novartis Investigative Site, Fredericksburg

23229

Novartis Investigative Site, Richmond

23606

Novartis Investigative site, Newport News

28152

Novartis Investigative Site, Shelby

28207

Novartis Investigative Site, Charlotte

29303

Novartis Investigative Site, Spartanburg

29379

Novartis Investigative Site, Union

29407

Novartis Investigative Site, Charleston

29615

Novartis Investigative Site, Greenville

29640

Novartis Investigative Site, Easley

32435

Novartis Investigator Site, DeFuniak Springs

32503

Novartis Investigative Site, Pensacola

32504

Novartis Investigative Site, Pensacola

33021

Novartis Investigative Site, Hollywood

33145

Novartis Investigator Site, Miami

33321

Novartis Investigative Site, Tamarac

33603

Novartis Investigator Site, Tampa

33765

Novartis Investigator Site, Clearwater

35501

Novartis Investigator Site, Jasper

35630

Novartis Investigator Site, Florence

38501

Novartis Investigator Site, Cookeville

41017

Novartis Investigator Site, Florence

42431

Novartis Investigator Site, Madisonville

43215

Novartis Investigator Site, Columbus

43608

Novartis Investigator Site, Toledo

43907

Novartis Investigator Site, Cadiz

44718

Novartis Investigator Site, Canton

55402

Novartis Investigator Site, Minneapolis

55432

Novartis Investigator Site, Fridley

55435

Novartis Investigator Site, Edina

62269

Novartis Investigator Site, O'Fallon

63141

Novartis Investigator Site, St Louis

65721

Novartis Investigator Site, Ozark

68123

Novartis Investigator Site, Bellevue

68134

Novartis Investigator Site, Omaha

68510

Novartis Investigator Site, Lincoln

70570

Novartis Investigator Site, Opelousas

72143

Novartis Investigator Site, Searcy

75069

Novartis Investigator Site, McKinney

76104

Novartis Investigator Site, Fort Worth

77539

Novartis Investigator Site, Dickinson

80033

Novartis Investigator Site, Wheat Ridge

84107

Novartis Investigator Site, Salt Lake City

85006

Novartis Investigator Site, Phoenix

89014

Novartis Investigator Site, Henderson

89119

Novartis Investigator Site, Las Vegas

89183

Novartis Investigator Site, Las Vegas

92120

Novartis Investigator Site, San Diego

92270

Novartis Investigative Site, Rancho Mirage

92506

Novartis Investigator Site, Riverside

92591

Novartis Investigator Site, Temecula

92835

Novartis Investigator Site, Fullerton

94598

Novartis Investigator Site, Walnut Creek

95207

Novartis Investigator Site, Stockton

97404

Novartis Investigative Site, Eugene

97504

Novartis Investigator Site, Medford

98405

Novartis Investigator Site, Tacoma

06033

Novartis Investigative Site, Glastonbury

06902

Novartis Investigative Site, Stamford

03756

Novartis Investigator Site, Lebanon

08003

Novartis Investigative Site, Cherry Hill

29406-7108

Novartis Investigative site, Charleston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY